OncoCyte is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.
http://investors.oncocyte.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
0.5 seconds
16x16
PAGES IN
THIS WEBSITE
14
SSL
EXTERNAL LINKS
3
SITE IP
52.85.77.169
LOAD TIME
0.456 sec
SCORE
6.2
Investor Relations – OncoCyte Corporation | investors.oncocyte.com Reviews
https://investors.oncocyte.com
OncoCyte is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.
investors.oncocyte.com
Board of Directors – OncoCyte Corporation
http://investors.oncocyte.com/corporate-governance/board-of-directors
Skip to main content. Alfred D. Kingsley. Chairman of the Board. Mr Kingsley holds a BS degree in economics from the Wharton School of the University of Pennsylvania, and a J.D. degree and LLM in taxation from New York University Law School. Mr Annett holds an MBA from the Harvard Business School. He is a graduate of George Washington University. Andrew J. Last. Mr Mohanty received an MBA degree from Saint Mary’s College and has an MS and BS in Chemical Engineering. 1010 Atlantic Avenue, Suite 102.
Press Releases – OncoCyte Corporation
http://investors.oncocyte.com/news-releases
Skip to main content. Register for email alerts. Mar 06, 2017. OncoCyte Reports Successful Results of Lung Cancer Diagnostic Test Study; Targets 2017 Product Launch to Address $4 Billion-plus Market. Mar 01, 2017. OncoCyte Corporation to Present at Cowen and Company 37th Annual Health Care Conference. Feb 27, 2017. OncoCyte Corporation Reports Fourth Quarter and Full Year 2016 Financial Results. Feb 21, 2017. OncoCyte Receives $2 Million in Proceeds from Early Exercise of Warrants. Feb 13, 2017.
Committees – OncoCyte Corporation
http://investors.oncocyte.com/corporate-governance/committees
Skip to main content. Andrew J. Last. 1010 Atlantic Avenue, Suite 102. Alameda, CA 94501.
Company Profile – OncoCyte Corporation
http://investors.oncocyte.com/company-profile
Skip to main content. A Revolution In Cancer Diagnostics. OncoCyte is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. We are developing non-invasive molecular diagnostics for earlier and more accurate detection which will:. Significantly reduce healthcare costs. Increase the life expectancy of cancer patients. 1010 Atlantic Avenue, Suite 102. Alameda, CA 94501.
SEC Filings – OncoCyte Corporation
http://investors.oncocyte.com/sec-filings
Skip to main content. Register for email alerts. 1010 Atlantic Avenue, Suite 102. Alameda, CA 94501.
TOTAL PAGES IN THIS WEBSITE
14
Goodman Property Trust investor centre | GMT investor centre | Goodman New Zealand
Goodman Property Trust Units. Goodman Property Trust Bonds. Goodman Property Trust investor centre. Goodman Property Trust investor centre. Goodman Property Trust is a listed Unit Trust that invests in high quality industrial and business space property in New Zealand. It is an established business built around a modern portfolio, a wide customer base and a proven development capability. For more information about Goodman Property Trust Units. For more information about Goodman Property Trust Bonds.
O-I - Investors - Investors
How Glass Is Made. Owens-Illinois has a history of being an industry leader - beginning when Michael J. Owens revolutionized the glass-making process and set new precedents in technology innovation, productivity, and production affordability. Today, those same key benefits - along with continual investment in research, develo. 160; 0.26. Data as of 08/07/15 4:02 pm ET. Minimum 20 minute delay. There are currently no items available. O-I ANNOUNCES SECOND QUARTER 2015 EARNINGS CONFERENCE CALL AND WEBCAST.
O'Brien Energy Company |
Experience. Integrity. Innovation. Determination. These are the fundamentals that drive our success. If you need further assistance, please contact Investor Services at. Enter your username (email address) and password to login. 425 Ashley Ridge Blvd., Suite 300. Shreveport, LA 71106. 2017 O'Brien Energy Company. Powered by: Synapse CMS.
Investors - Ocular Therapeutix
Ocular Therapeutix, Inc. Ocular Therapeutix, Inc. Q2 2015 Ocular Therapeutix, Inc. Earnings Conference Call. 160;at 5:00 pm ET. Q2 2015 Ocular Therapeutix, Inc. Earnings Conference Call. Monday, August 10, 2015 . 5:00 pm ET . Click here for webcast. Click here to add this event to your calendar. Founded in 2006, Ocular Therapeutix is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye. 160; 0.32. Return to top of page.
investors.oiltankingpartners.com
Oiltanking Partners - Company Profile
Oiltanking Partners, L.P. is a growth-oriented publicly traded master limited partnership (MLP) engaged in the terminaling, storage and transportation of crude oil, refined petroleum products and liquefied petroleum gas. We completed our initial public offering in July 2011 and trade under the symbol (NYSE : OILT). 2012 Letters to Unitholders and 10-K. 160; 0.32. Enterprise Products and Oiltanking Partners Complete Merger. Oiltanking Partners Declares Increase in Quarterly Distribution. HOUSTON- (BUSINES...
Investor Relations – OncoCyte Corporation
Skip to main content. OncoCyte is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. OncoCyte Senior Management Rings NYSE Opening Bell. OncoCyte Chairman and CEO at Bell ringing ceremony. Pipeline positioned to capitalize on standard of care moving to liquid biopsy. Early diagnosis focused on the largest market segment with the greatest unmet needs. Clinical data demonstrates strong assay performance.
Investor Centre – onthehouse.com.au
Welcome to our new Investor Centre. Helping you make smarter property investment decisions. Hey Man, Do You Dig It? Author: Kieran Clair Source: API Magazine. Hipsters are setting a property agenda that’s signalling great investment opportunities for those with a groovy bent. How China's Share Market Could Affect Australian Property. Author: Peter McGuire Source: N G Farah. ATO Creates New System for Contribution Reserving Strategies. Author: Katarina Taurian Source: SMSF Adviser. Author: Dinah Lewis Bou...
oOh! Media - Investor Centre
Gain access to some of the most sought after and visible sites in the country. Make your presence felt at the very time people are most interested in buying. Engage with consumers throughout their journey. Place-based media reaches a targeted demographic through a specially located network of screens in café, venues, uni's, sport centres - displaying tailored and consistent messaging throughout the day. Involve potential customers in an experience they simply won't forget. Announcements and Media Releases.
Investors relations - Open Finance - Investors Relations
Umów się na bezpłatne spotkanie z Doradcą! Open Finance's Shares on the Stock Exchange. Current report 63/2012 r. NOTIFICATION UNDER ARTICLE 69 OF THE POLISH ACT ON PUBLIC OFFERING. Current report 62/2012 r. REPORT OF TRANSACTIONS INVOLVING OPEN FINANCE S.A. SECURITIES. August 07, 2015. Raport for the first quarter of 2011 12 May 2011. Half-yearly report for 2011 29 August 2011. News and Press Releases. Open Finance Group’s Results. Open Finance Group's Results. Open Finance Group records good results.
Investor Relations | OpenText
OpenText welcomes John Doolittle as new Chief Financial Officer. Mark J. Barrenechea, OpenText President and CEO opens the market to celebrate 15 years as a Toronto Stock Exchange listed company. Annual Reports View More ». Quarterly Reports View More ». Contact Us View More ». OpenText Reports Fourth Quarter and Fiscal Year 2015 Financial Results. FY2015 Q4 Financial Statements. FY2015 Q4 Strategic Overview & Investor Relations. FY2015 Q4 Supplemental Investor Presentation. FY2015 Q4 Financial Results.
Investors | Ophthotech
Day High: 52.09. Day Low: 50.00. Aug 17, 2015. Delayed at least 20 min., by eSignal. View all ». Aug 5, 2015. Ophthotech Reports Second Quarter 2015 Financial and Operating Results. Jul 29, 2015. Ophthotech Corporation to Report Second Quarter 2015 Financial Results and Host Conference Call on Wednesday, August 5, 2015.
